Coca-Cola Buys Acque Minerali

Coca-Cola buys Acque Minerali.
   
Coca-Cola Hellenic Bottling Company buys Acque Minerali for $97 million.
   
Founded in 1940 in Roccaforte Mondovì, Acque Minerali makes and distributes natural mineral water and adult sparkling beverages under the Lurisia brand.  In the water category, the company offers still and sparkling water in PET and glass packaging, sourced from springs 1,400 meters above sea level in Monte Pigna.  The company was a pioneer in offering water products in bell-shaped glass bottles, designed by Studio Sottsass Associati.
  
In the adult sparkling category, Lurisia offers beverages inspired by authentic Italian recipes, based on local ingredients.  The variations are Chinotto, Gazzosa, Aranciata, Aranciata Rossa, Aranciata Amara, Limonata, and Tonica.  Lurisia products enjoy high brand awareness associated with quality, authenticity, taste, and the Italian lifestyle.  Since 2008, the company has partnered in the main events organized by Slow Food, a non-profit organization set up in 1986 promoting local food and traditional cooking.
  
The acquisition of Lurisia complements the existing Coca Cola HBC beverage portfolio in Italy and is a strong fit for the company’s total beverage partner strategy.  It supports the company’s drive to upgrade its portfolio and offer an authentic Italian brand with a strong heritage and well-rooted Italian origins.
   
The selling shareholders are private equity firm IDeA Taste of Italy, the Invernizzi family, and Eataly Distribuzione.  Piero Bagnasco of Lurisia and Alessandro Invernizzi will remain on the Acque Minerali board of directors.
   
UBS served as financial adviser to Coca Cola HBC.

Comments

Post a Comment

Popular posts from this blog

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy ...
Read more

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. T...
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address ...
Read more